Company Overview - New Era Energy & Digital, Inc. develops and operates digital infrastructure and integrated power assets [3] Allegations of Wrongdoing - On December 12, 2025, a report by Fuzzy Panda Research accused New Era of prioritizing stock promotion over its core oil and gas operations, leading to a stock price drop of $0.25 per share, or 6.9%, closing at $3.35 on December 13, 2025 [4] - On December 29, 2025, a lawsuit was filed by the State of New Mexico against New Era and its CEO, alleging fraudulent operations and shifting environmental cleanup costs to the state, resulting in a further stock price decline of $2.19 per share, or 48.03%, closing at $2.37 per share [5] Legal Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving New Era, stemming from allegations of misleading business information provided to investors [1]

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1]. Company Overview - Integer Holdings Corporation specializes in designing and manufacturing cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. Allegations of Securities Fraud - The lawsuit claims that Integer misrepresented the demand and revenue for its electrophysiology products, which had reportedly fallen sharply, contradicting the company's public statements about sales growth and market position [5][4]. Stock Price Decline - On October 23, 2025, Integer revised its 2025 sales guidance down to a range of $1.840 billion to $1.854 billion from a previous range of $1.850 billion to $1.876 billion, which was below analysts' expectations. The company also projected a net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026. This announcement led to a stock price drop of $35.22 per share, or over 32%, from $109.11 to $73.89 [6].

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and liability reserves, leading to significant financial losses for investors during the specified class period [1][3]. Company Overview - Ardent Health, Inc. operates a network of hospitals and clinics providing various healthcare services [2]. Allegations of the Lawsuit - The lawsuit claims that Ardent Health did not rely on accurate methods for determining the collectability of accounts receivable, which allowed the company to report inflated financial figures [3]. - It is alleged that Ardent Health's accounts receivable framework utilized a "180-day cliff" for reserving accounts, delaying the recognition of losses on uncollectible accounts [3]. - The company reportedly lacked sufficient professional malpractice liability insurance and reserves to cover claims, particularly in light of increasing social inflationary pressures in the New Mexico market [3]. Financial Impact - On November 12, 2025, Ardent Health disclosed a $43 million decrease in third quarter 2025 revenue due to revised accounts receivable collectability assessments and a new revenue accounting system [4]. - The company also cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million - $615 million to $530 million - $555 million, citing persistent industry-wide cost pressures [4]. - Additionally, a $54 million increase in professional liability reserves was recorded due to recent settlements and ongoing litigation, reflecting broader industry trends [4]. - Following these announcements, Ardent Health's stock price fell nearly 34% [4]. Legal Process - Investors who purchased Ardent Health securities during the class period can seek to be appointed as lead plaintiff in the lawsuit, representing the interests of the class [5]. - The lead plaintiff has the authority to select a law firm for litigation and does not need to be the lead plaintiff to share in any potential recovery [5]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has a strong track record in obtaining significant recoveries in securities class action cases, including the largest recovery in history [6].

RADNOR, Pa., Jan. 8, 2026 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Sprouts Farmers Market, Inc. ("Sprouts") (NASDAQ: SFM) on behalf of those who purchased or otherwise acquired Sprouts securities between June 4, 2025, and October 29, 2025, inclusive (the "Class Period"). The lead plaintiff deadline is January 26, 2026. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:If you suffered Sprouts lo ...

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE:ARDT) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-act ...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Varonis Systems, Inc. ("Varonis†or the "Company†) (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, inclusive (the "Class Period†). Varonis investors have until March 9, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN VARONIS SYSTEMS, INC. (VRNS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO ...

Philadelphia, Pennsylvania--(Newsfile Corp. - January 8, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Skye Bioscience, Inc. (NASDAQ: SKYE) ("Skye" or the "Company") on behalf of investors who purchased or otherwise acquired Skye securities during the period of November 4, 2024 through October 3, 2025 (the "Class Period"), inclusive.Investor Deadline: Investors who purchased Skye securities during the Class Period may, no later than Ja ...

Philadelphia, Pennsylvania--(Newsfile Corp. - January 8, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company") on behalf of investors who purchased or otherwise acquired Jayud securities during the period of April 21, 2023 through April 30, 2025 (the "Class Period"), inclusive.Investor Deadline: Investors who purchased Jayud securities during the Class Period may, no later ...

Philadelphia, Pennsylvania--(Newsfile Corp. - January 8, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) ("Stride" or the "Company") on behalf of investors who purchased Stride securities during the period of October 22, 2024 through October 28, 2025 (the "Class Period").Investor Deadline: Investors who purchased Stride securities during the Class Period may, no later than January 12, 2026, seek to be appointed a ...

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Charming Medical Ltd. (NASDAQ: MCTA) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Charming securities between October 10, 2025 and November 12, 2026, b ...